Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Motor Activity 12Breast Neoplasms 9Fatigue 8Neoplasms 7Cognitive Dysfunction 3Colorectal Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Postoperative Bowel Functions 1Polycystic Ovary Syndrome 1Parasomnias 1Obesity 1Metabolic Syndrome 1Lymphoma, Follicular 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Asthenia 1Arthralgia 1Adenomatous Polyps 1

Interventions

Rituximab 295Cyclophosphamide 240Peripheral Blood Stem Cell Transplantation 114fludarabine phosphate 110Filgrastim 93Etoposide 85Radiotherapy 81Lenalidomide 79Vincristine 78Prednisone 77Mycophenolic Acid 66Doxorubicin 61Cyclosporine 59Whole-Body Irradiation 58Bendamustine Hydrochloride 58Melphalan 57Tacrolimus 53Busulfan 51fludarabine 50Cytarabine 48obinutuzumab 46Methotrexate 45Antilymphocyte Serum 43Bortezomib 42Methylprednisolone 37Carmustine 37sargramostim 36ibritumomab tiuxetan 32ibrutinib 30Dexamethasone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma, Follicular × Walking × Clear all
NCT06495190 2025-03-12

Cognition, Flavonoids, Exercise, Gut Microbiome

Appalachian State University

Phase NA Recruiting
240 enrolled
Lymphoid

Lymphoma, Follicular, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡